Álvarez-Hernández, P.; Patier, J.L.; Marcos, S.; Gómez del Olmo, V.; Lorente-Herraiz, L.; Recio-Poveda, L.; Botella, L.M.; Viteri-Noël, A.; Albiñana, V.
Tacrolimus as a Promising Drug for Epistaxis and Gastrointestinal Bleeding in HHT. J. Clin. Med. 2023, 12, 7410.
https://doi.org/10.3390/jcm12237410
AMA Style
Álvarez-Hernández P, Patier JL, Marcos S, Gómez del Olmo V, Lorente-Herraiz L, Recio-Poveda L, Botella LM, Viteri-Noël A, Albiñana V.
Tacrolimus as a Promising Drug for Epistaxis and Gastrointestinal Bleeding in HHT. Journal of Clinical Medicine. 2023; 12(23):7410.
https://doi.org/10.3390/jcm12237410
Chicago/Turabian Style
Álvarez-Hernández, Paloma, José Luis Patier, Sol Marcos, Vicente Gómez del Olmo, Laura Lorente-Herraiz, Lucía Recio-Poveda, Luisa María Botella, Adrián Viteri-Noël, and Virginia Albiñana.
2023. "Tacrolimus as a Promising Drug for Epistaxis and Gastrointestinal Bleeding in HHT" Journal of Clinical Medicine 12, no. 23: 7410.
https://doi.org/10.3390/jcm12237410
APA Style
Álvarez-Hernández, P., Patier, J. L., Marcos, S., Gómez del Olmo, V., Lorente-Herraiz, L., Recio-Poveda, L., Botella, L. M., Viteri-Noël, A., & Albiñana, V.
(2023). Tacrolimus as a Promising Drug for Epistaxis and Gastrointestinal Bleeding in HHT. Journal of Clinical Medicine, 12(23), 7410.
https://doi.org/10.3390/jcm12237410